Pushkar Pharma is a WHO-GMP and ISO 9001:2008 certified eye ointment manufacturer based in Kala-Amb, Himachal Pradesh, operating a 7,000+ sq. yard facility with ISO Class 5 sterile filling rooms.
The company manufactures ophthalmic ointments including antibiotic (Moxifloxacin, Tobramycin), anti-inflammatory, and steroid-combination (Hydrocortisone) formulations for third-party and private-label contract manufacturing. Every batch undergoes sterility testing (membrane filtration, 14-day incubation), HPLC-based active concentration testing (95–105% of specified API), and particle size analysis (below 50 microns). Third-party manufacturing batches start at ₹1.5–5 lakh depending on API, packaging, and volume, with a minimum order of 3,000–5,000 tubes and a 30–45 day production cycle.
Why Should You Partner with Eye Ointment Manufacturers in India?
High-Purity Sterile Formulations
Sterile eye ointment manufacturing requires ISO Class 5 filling environments with automatic filling lines, since particulate contamination above pharmacopeial limits (typically 50 microns) can cause ocular irritation. This is why particle size testing via laser diffraction or microscopic analysis is a standard release check before any batch ships.
Wide Range of Formulated Ophthalmics
Ophthalmic ointment manufacturers typically offer five core categories: antibiotic, anti-inflammatory, lubricating, antiviral, and steroid-combination ointments. A manufacturer covering all five in one facility lets a brand consolidate its full eye-care line with a single contract partner instead of splitting production across vendors.
Low Cost of Third-Party Production Model
Third-party manufacturing removes the need to build and license your own sterile facility, which for ophthalmic products can run into crores in capital cost. Brands instead pay per batch — commonly ₹1.5–5 lakh depending on API, packaging, and volume — and redirect the capital they’d have spent on infrastructure into marketing and distribution.
Multi-Stage Batch Verification
Batch verification for ophthalmic ointments runs at three checkpoints: raw material testing before production, in-process sterility and HPLC concentration checks during filling, and a final release test covering seal integrity via vacuum leak detection. Leak-free sealing is critical because a compromised seal can void sterility even if the formulation itself passed earlier tests.
Regulatory Export Compliance
Exporting ophthalmic ointments requires WHO-GMP certification at minimum, plus a Certificate of Analysis (COA) and HPLC test data for each batch, since importing countries generally won’t clear pharmaceutical shipments without documented proof of sterility and API concentration.
How Do Eye Ointment Manufacturers Ensure Product Quality and Safety?
Eye ointment quality is verified through five checks before a batch is released: sterility (membrane filtration, no microbial growth after 14 days), active concentration (HPLC, 95–105% of specified API), particle size (below 50 microns), seal integrity (vacuum leak test), and metallic particulate limits (max 50 particles across 10 sample tubes).
| Quality Control Parameter | Testing Method & Equipment | Standard Acceptance Criteria |
|---|---|---|
| Sterility | Membrane filtration method | No microbial growth after 14 days of incubation |
| Active Concentration | HPLC analysis | 95.0%–105.0% of the specified API concentration |
| Particle Size Analysis | Microscopic analysis / laser diffraction | Solid particles controlled below 50 microns to minimize eye irritation |
| Seal Integrity Test | Vacuum leak detection | Leak-free seal performance under negative pressure |
| Metallic Particulate Limits | Pharmacopeial ophthalmic inspection | Maximum 50 metal particles across 10 sample tubes |
What Factors Must Be Taken into Account While Choosing the Eye Ointment Manufacturers in India?
Choosing an eye ointment contract manufacturer comes down to five checks: verified WHO-GMP, ISO 9001:2008, and state drug license status; an ISO Class 5 sterile filling room; enough production capacity to cover peak demand; batch-level COA and HPLC data on request; and tamper-evident packaging such as aluminum or lami-tubes.
- Validate the validity of WHO-GMP, ISO 9001:2008 & state drug manufacturing license.
- Ensure that there is a modern ISO Class 5 filling room at the facility for sterile filling during ophthalmic ointment manufacturing.
- Ensure the output capability of the factory to avoid supply limitations during peak periods of demand.
- Request COA and HPLC test results for every single batch.
- Ask about the type of packaging used by the partner, such as tamper-evident aluminum tubes or lami-tubes.
By collaborating with accredited eye ointment manufacturers, you will guarantee compliance with national pharmacopeial standards. Hence, pharmaceutical companies avoid quality variations and build up credibility in the market.
Why Is It Important to Collaborate with Pushkar Pharma as Your Eye Ointment Manufacturer?
Experienced Pharmaceutical Manufacturing Company
We offer extensive experience in sterile pharmaceutical manufacturing. Also, the qualified technical staff ensures that all the batches are consistent in every product line.
State-of-the-art Kala-Amb Factory
Pushkar Pharma manufactures eye ointments at a 7,000+ sq. yard facility in Kala-Amb, Himachal Pradesh, with dedicated ISO Class 5 sterile filling rooms for ophthalmic production.
Broad Portfolio of Available Formulations
Pushkar Pharma manufactures Moxifloxacin, Tobramycin, and Hydrocortisone eye ointments, covering antibiotic, antibiotic-combination, and steroid categories for third-party and private-label partners.
Affordable Third-Party Contract Price
Third-party manufacturing packages start from ₹1.5 lakh per batch, scaling with API, packaging, and order volume — giving smaller brands a lower entry cost than building an in-house sterile facility.
Reliable Nationwide Logistics System
With a great record of prompt deliveries, Pushkar Pharma provides fast product delivery all over the country. Moreover, due to the effective logistics chain, partners never run out of the product.
Conclusion
Choosing reliable eye ointment manufacturers is an essential part of establishing an efficient ophthalmic brand. The Pushkar Pharma ophthalmic ointment manufacturing firm is a leader among eye ointment producers with WHO-GMP certification and analytical testing.
Frequently Asked Questions
1. What is the average manufacturing cycle of eye ointments?
The typical third-party eye ointment manufacturing cycle takes 30–45 days, covering formulation, sterile filling, batch testing, and packaging.
2. What is the minimum order quantity of Contract Manufacturing?
Minimum order quantity for third-party eye ointment manufacturing usually starts at 3,000–5,000 tubes per batch, though this can vary by formulation and packaging type.
3. Why is ophthalmic ointment utilized instead of eye drop solution?
Advantages of ophthalmic ointments are long-lasting ocular retention, high drug bioavailability, and reduced frequency of doses compared to eye drops.
4. What quality certificates are there with Pushkar Pharma?
We holds WHO-GMP, ISO 9001:2008, GLP and state licenses for drug manufacturing.
5. How is sterility of ophthalmic ointments achieved?
Ophthalmic ointments are packed in tamper-proof aluminum tubes or multi-layered lami-tubes.
6. Does Pushkar Pharma provide formulations for private labels?
Yes, we supplies formulations customization, private labeling and packaging design for businesses and franchises.
7. How is metal particles presence in ophthalmic ointments detected?
Technicians melt the sample base and examine it under a microscope to confirm no metallic particles exceed pharmacopeial limits.
8. What is the shelf life of ophthalmic ointments?
Sterile ophthalmic ointments shelf life is 24 months in storage conditions below 25°C.
9. Does Pushkar Pharma provide assistance in export documentation of eye care products?
Yes, we provides complete set of regulatory documents, Certificates of Analysis (COA) and logistic support.